BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22941762)

  • 1. MODY 2 diabetes in a mature newborn due to a new mutation in the GCK-gene.
    Fahr K; Böckmann A; Wildhardt G; Gessler P
    Klin Padiatr; 2012 Sep; 224(5):316-7. PubMed ID: 22941762
    [No Abstract]   [Full Text] [Related]  

  • 2. GCK monogenic diabetes and gestational diabetes: possible diagnosis on clinical grounds.
    Flack JR; Ross GP; Cheung NW
    Diabet Med; 2015 Dec; 32(12):1596-601. PubMed ID: 26043405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monogenic diabetes caused by GCK gene mutation is misdiagnosed as gestational diabetes - A multicenter study in Portugal.
    Lima Ferreira J; Voss G; Sá Couto A; Príncipe RM
    Diabetes Metab Syndr; 2021; 15(5):102259. PubMed ID: 34438359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
    Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Glucokinase Monogenic Diabetes in a Multiethnic Gestational Diabetes Mellitus Cohort: New Pregnancy Screening Criteria and Utility of HbA1c.
    Rudland VL; Hinchcliffe M; Pinner J; Cole S; Mercorella B; Molyneaux L; Constantino M; Yue DK; Ross GP; Wong J
    Diabetes Care; 2016 Jan; 39(1):50-2. PubMed ID: 26109503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of maturity-onset diabetes of the young in a cohort of Chinese children.
    Xu A; Lin Y; Sheng H; Cheng J; Mei H; Ting TH; Zeng C; Liang C; Zhang W; Li C; Li X; Liu L
    Pediatr Diabetes; 2020 May; 21(3):431-440. PubMed ID: 31957151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of diabetes mellitus.
    American Diabetes Association
    Diabetes Care; 2012 Jan; 35 Suppl 1(Suppl 1):S64-71. PubMed ID: 22187472
    [No Abstract]   [Full Text] [Related]  

  • 8. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.
    Stanik J; Dusatkova P; Cinek O; Valentinova L; Huckova M; Skopkova M; Dusatkova L; Stanikova D; Pura M; Klimes I; Lebl J; Gasperikova D; Pruhova S
    Diabetologia; 2014 Mar; 57(3):480-4. PubMed ID: 24323243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY).
    Boesgaard TW; Pruhova S; Andersson EA; Cinek O; Obermannova B; Lauenborg J; Damm P; Bergholdt R; Pociot F; Pisinger C; Barbetti F; Lebl J; Pedersen O; Hansen T
    BMC Med Genet; 2010 Mar; 11():42. PubMed ID: 20226046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MODY diabetes and screening of gestational diabetes.
    Urbanová J; Brunerová L; Nunes MA; Brož J
    Ceska Gynekol; 2020; 85(2):124-130. PubMed ID: 32527107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes and pregnancy].
    Schäfer-Graf U; Kleinwechter H
    MMW Fortschr Med; 2010 May; 152(18):37-40. PubMed ID: 20514762
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperglycaemia and β-cell antibodies: is it always pre-type 1 diabetes?
    d'Annunzio G; Marchi M; Aloi C; Salina A; Lugani F; Lorini R
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e20-2. PubMed ID: 23352578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucokinase Deficit Prevalence in Women With Diabetes in Pregnancy: A Matter of Screening Selection.
    Bitterman O; Giuliani C; Festa C; Napoli A
    Front Endocrinol (Lausanne); 2020; 11():268. PubMed ID: 32508747
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications.
    Naylor RN; John PM; Winn AN; Carmody D; Greeley SA; Philipson LH; Bell GI; Huang ES
    Diabetes Care; 2014; 37(1):202-9. PubMed ID: 24026547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)].
    Datz N; Nestoris C; von Schütz W; Danne T; Driesel AJ; Maringa M; Kordonouri O
    Dtsch Med Wochenschr; 2011 May; 136(21):1111-5. PubMed ID: 21590629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (2) Classification and diagnosis of diabetes.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S8-S16. PubMed ID: 25537714
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).
    Firdous P; Hassan T; Nissar K; Masoodi SR; Ganai BA
    Prim Care Diabetes; 2022 Apr; 16(2):325-332. PubMed ID: 35131168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of a glucokinase gene mutation and description of its clinical phenotype.
    Hunter JD; Staton H; Constantacos C; Walsh ET; Crudo DF
    Pediatr Diabetes; 2020 Sep; 21(6):942-944. PubMed ID: 32468610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of maternal diabetes on visual evoked potentials and early psychomotor development of the offspring.
    Brinciotti M; Matricardi M; Colatrella A; Torcia F; Fallucca F; Napoli A
    Diabetes Care; 2007 Dec; 30(12):e128. PubMed ID: 18042737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.